The state's largest health network and largest health insurer have shown marked reductions or slower growth in the use of services as part of their three-year-old accountable-care organization, an encouraging sign as providers and payers try to reduce the cost of care.
The state's largest health network and largest health insurer have shown marked reductions or slower growth in the use of services as part of their three-year-old accountable-care organization, an encouraging sign as providers and payers try to reduce the cost of care.
Advocate Health Care and Blue Cross & Blue Shield of Illinois started their ACO, called AdvocateCare, three years ago aiming to better align financial incentives between the two mammoth organizations. The utilization trends, which Blue Cross provided to Crain's, provide a glimpse into the progress of one of the country's first and largest commercial ACOs.
Similar to the Medicare accountable-care organizations established by President Barack Obama's health reform law, the Advocate-Blues venture pays doctors and hospitals based on how well they meet quality, patient satisfaction and cost metrics for a defined population of about 380,000 members, rather than the traditional fee-for-service model. The ACO does not include all Advocate patients covered by Blue Cross.
Read the full story here: http://bit.ly/1fbSbgK
Source: Chicago Healthcare Daily
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen